Skip Ribbon Commands
Skip to main content

Dr Fok Wai Yee Rose

Dr Fok Wai Yee Rose

MBBS, GDMH, GDFM, MMed (Family Med), FCFP(S)

Associate Consultant

Specialty: Family Medicine

Conditions Treated by this Doctor:
Breast Cancer , Cancer Genetics, Gynaecological Cancers.

Clinical Appointments

  • Associate Consultant Division of Medical Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore


Dr. Rose Fok is a family physician who practices at National Cancer Centre Singapore, caring for Breast & Gynae Cancer Survivors and high-risk surveillance for mutation positive patients. She also practices at Sing-Health Polyclinics (SHP), caring for patients with complex primary care conditions.

Dr Fok has a deep interest in health services research, especially in the areas of community cancer survivor-ship, transitional care and innovative integrated care delivery models. She is involved in various studies in oncology and family medicine, both in the capacity of principal and co-investigator. She is a keen educator and is a faculty and ethics lead at the College of Family Physicians Singapore, Master of Medicine (Family Medicine) programme.


  • Fellow, College of Family Physicians (Singapore)
  • Master of Medicine (Family Medicine)
  • Grad Dip Family Medicine
  • Grad Dip Mental Health

Professional Appointments and Committee Memberships

  • Member, Steering Committee of SPRINT (Singapore PRImary Care Cancer NeTwork) – 2020 till present
  • Member, Asia-Pacific Primary Care Cancer Research Network – 2020 till present
  • Member, Preventive & early detection sub-committee, National Advisory Committee on cancer – 2019 till present
  • Council Member, College of Family Physician Singapore – 2019 till present
  • Member, National-GP IT Workgroup for GP Connect EMR – 2014 to 2016


Research Interests

  • Cancer survivorship and high-risk surveillance
  • Mental health
  • Health services research
  • Care transition and care delivery models


  • Fok WY, et al, Chan A, Tan NC. Roles and recommendations from primary care physicians towards managing low-risk breast cancer survivors in a shared-care model with specialists in Singapore—a qualitative study. Family Practice. 2020 Feb 7.
  • Fok WY, FF Vasanwala, Low SG: Understanding and navigating mental health resources in the com-munity through a case study. The Singapore Family Physician Vol 46(6) September 2020:34-39
  • Fok WY, Kiley Loh: Cancer Survivorship – more than just surviving cancer The Singapore Family Physician Vol 46(2) Mar 2020:42-45
  • Fok WY, Low SG, FF Vasanwala: A new lease of life – living with disability and renal dialysis. The Singapore Family Physician Vol 45(6) July-September 2019:25-29
  • Fok WY, Low SG, FF Vasanwala: Hospital-to-Home: a model for transition of care. The Singapore Family Physician Vol 45(3) April-June 2019:31-35 • Chan A, et al, Fok WY. Practitioners’ perspectives on community‐based breast cancer survivorship care in Singapore: A focus group study. Health & social care in the community. 2018 May;26(3):404-11.
  • Chan A, et al, Fok WY, Loh KW. Perceptions and barriers of survivorship care in Asia: perceptions from Asian breast cancer survivors. Journal of global oncology. 2017 Apr;3(2):98-104.

Research Trials

  • Impact of a Breast cAncer Survivorship Inter-professional Community care model (BASIC): A Ran-domized Controlled Trial
  • Development and pilot testing of a decision aid for breast cancer survivors considering shared-care survivorship follow-up model
  • Following Up on the Follow Up—Looking into Breast cancer patients and their carers’ views on follow-up care
  • Exploring perceptions of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high risk group
  • Perceptions of primary care physicians regarding public health preparedness clinic scheme for Covid-19 in Singapore
  • Understanding the educational and infrastructure needs of primary care physicians’ towards clinical genomic testing
  • Supportive and survivorship care program for cancer patients: a cluster randomized controlled pilot study among breast and gynaecological cancer patients
  • Pharmacogenetics and its influence on Tamoxifen Pharmacokinetics and Clinical Outcome in Asian Breast Cancer Patients